Patent · US Active

Vaccines against Zika virus based on Zika structure proteins

US11078491B2 · kind B2 · utility

0Cited by

4References

11Claims

0Family size

Assignee

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · US

Inventors

Qiang Chen · Sollentuna, SE
Haiyan Sun · 安丰镇, CN
Huafang Lai · Chandler, US
Ming-Hui Yang · Chandler, US

Key dates

Filing date	May 24, 2018
Grant date	Aug 3, 2021
Priority date	—
Expiry date	May 24, 2038

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Compositions including a virus-like particle (VLP)-based vaccine displaying a portion of ZIKV envelope protein (E) domain III (DIII) and a portion of ZIKV envelope protein (E) and related methods are disclosed herein. Further, compositions including vaccines comprising a portion of ZIKA virus E protein, wherein the portion of ZIKA virus E protein is either a full-length version of ZIKA virus E protein or a functionally equivalent version of the full-length ZIKA virus E protein, are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.